Recent reports have suggested that background levels of industrial chemicals and other environmental pollutants may play a role in development of breast cancer in women and decreased male reproductive success as well as the reproductive failures of some wildlife species (1) (2) (3) (4) (5) (6) . These suggestions have been supported by articles in the popular and scientific press (7) (8) (9) (10) (11) (12) (13) and by a television documentary (14) which have described the perils of exposure to endocrine-disrupting chemicals such as estrogenic organochlorine pesticides and pollutants. During the past two decades, environmental regulations regarding the manufacture, use, and disposal of chemicals have resulted in significantly reduced emissions of most industrial compounds and their by-products. Levels of the more environmentally stable organochlorine pesticides and pollutants are decreasing in most ecosystems including the industrialized areas around the Great Lakes in North America (15) (16) (17) (18) . Decreased levels of organochlorine compounds correlates with the improved reproductive success of highly susceptible fish-eating water birds in the Great Lakes region (19) . This article reviews key papers that have been used to support the hypotheses that environmental estrogens play a role in the increased incidence of breast cancer in women and decreased sperm counts in males. Environmental/dietary estrogens and antiestrogens are identified and intakes of "estrogen equivalents" are estimated to compare the relative dietary impacts of various classes of estrogenic chemicals.
Role of Estrogens in Breast Cancer and Male Reproductive Problems
Concerns regarding the role of environmental and dietary estrogens as possible contributors to the increased incidence of breast cancer were fueled by several reports that showed elevated levels of organochlorine compounds in breast cancer patients (20) (21) (22) (23) (24) . The results presented in Table 1 summarize some of these studies that compare levels of organochlorine compounds in breast tissue or serum from breast cancer patients and controls. Polychlorinated biphenyls (PCBs) and 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) are the two most abundant organochlorine pollutants identified in all human tissues with high frequencies. In one Scandinavian study, levels of DDE or PCBs in adipose tissue from breast samples were not significantly different in breast cancer patients compared to controls (20) . In another study in Finland, P-hexachlorocyclohexane levels were elevated in breast cancer patients (21) ; however, this compound was not detected in adipose tissue of some individuals in the patient and control groups and has a relatively low frequency of detection in human tissue samples. Falck and co-workers reported that PCB levels were elevated in mammary adipose tissue samples from breast cancer patients in Connecticut (22) . In contrast, serum levels of DDE (but not PCBs) were significantly elevated in breast cancer patients enrolled in the New York University Women's Health Study (23) . DDE (but not PCB) levels were also elevated in estrogen receptor (ER)-positive but not ER-negative breast cancer patients from Quebec compared to levels in women with benign breast disease (24) . It was initially concluded by Wolff and co-workers that "these findings suggest that environmental chemical contamination with organochlorine residues may be an important etiologic factor in breast cancer" (22) . The correlations reported in the two U.S. studies (22, 23) heightened public and scientific concern regarding the potential role of these compounds in development of breast cancer. These observations undoubtedly reinforced advocacy by some groups for a ban on the use of all chlorine-containing chemicals. However (31) . These observations, coupled with the hypothesis that environmental estrogens including organochlorine chemicals were possible etiologic agents, were reported with alarm in the popular and scientific press (7-12) and in a BBC television program entitled "Assault on the Male: a Horizon Special" (14) . Subsequent and prior scientific studies have cast serious doubts on both the hypothesis (5) and the observed decrease in male sperm counts (31) . In 1979, Macleod and Wang (32) reported that there had been no decline in sperm counts, and reanalysis of the data presented by Carlsen and co-workers showed that sperm counts had not decreased from 1960 to 1990 (33 19 ).
These results suggest that the increasing incidence of human breast cancer is not related to organochlorine environmental contaminants and that decreases in sperm counts is highly debatable. Nevertheless, human populations are continually exposed to a wide variety of environmental and dietary estrogens, and these compounds clearly fit into the category of "endocrine disrupters." The remainder of this article briefly describes the different structural classes of both environmental and dietary estrogens and quantitates human exposures to these compounds.
Synthetic Industrial Chemicals with Estrogenic Activity
The estrogenic activities of different structural classes of industrial chemicals were reported by several research groups in the late 1960s and 1970s in which o,p'-DDT and other diphenylmethane analogs (Fig.  1 ) and the insecticide kepone were characterized as estrogens (35) (36) (37) (38) . Subsequent studies have confirmed the estrogenic activity of o,p-DDT and related compounds (39) whereas the p,p'-substituted analogs were relatively inactive (36, 37) . In addition, p,p'-methoxychlor and its hydroxylated metabolites elicit estrogenic responses (39, 40 Other industrial chemicals or intermediates that have been identified as estrogenic compounds include bisphenol-A (Fig. 1) , a chemical used in the manufacture of polycarbonate-derived products (45) ; phenol red, a pH indicator used in cell culture media (46) ; and alkyl phenols and their derivatives, which are extensively used for preparation of polyethoxylates in detergents (47, 48) .
Natural Estrogenic Compounds
Human exposure to estrogenic chemicals is not confined to xenoestrogens derived from industrial compounds. Several different structural classes of naturally occurring estrogens have been identified, including plant bioflavonoids (Fig. 1) (51, 52) .
Environmental and Dietary Antiestrogens
Several different structural classes of chemicals found in the human diet also exhibit antiestrogenic activity (Fig. 2) (60, 66, 67) . A recent epidemiology study on women exposed to TCDD after an industrial accident in Seveso (68) reported that breast cancer incidence was decreased in areas with high levels of TCDD contamination (particularly in the age class 45 to 74) and among women living longest in an area of low TCDD contamination. Endometrial cancer showed a remarkable decrease, particularly in areas with medium and low TCDD contamination (68) . Thus, TCDD and related compounds exhibit a broad spectrum of antiestrogenic activities and, not surprisingly, so do other AhR agonists such as the polynuclear aromatic hydrocarbons (PAHs), indole-3-carbinol (IC), and related compounds found in relatively high levels in foodstuffs (69, 70) . PAHs are found in cooked foods (71, 72) and are ubiquitous environmental contaminants. IC is a major component of cruciferous vegetables (e.g., brussels sprouts, cauli- (74) reported that the estrogenic bioflavonoids quercetin and luteolin (Fig. 1) inhibited E2-induced proliferation of MCF-7 human breast cancer cells and E2-induced uterine wet weight increase in 21-day-old female rats. Similar results were also observed in this laboratory for quercetin, resperetin, and naringenin. For example, the bioflavonoid naringenin inhibited estrogen-induced uterine hyptertrophy in female rats and estrogeninduced luciferase activity in MCF-7 cells transfected with an E2-responsive plasmid construct containing the 5'-promoter region of the pS2 gene and a luciferase reporter gene (unpublished results). In contrast, a recent study (75) reported that coumestrol, genistein, and zearalenone were not antiestrogenic in human breast cancer cells. The antiestrogenic activities of weak dietary and environmental estrogens require further investigation; however, it is clear that at subestrogenic doses, some of these compounds exhibit antiestrogenic activities in both in vivo and in vitro models.
Mass/Potency Balance
The uptake of environmental or dietary chemicals that elicit common biochemical/ toxic responses can be estimated by using an equivalency factor approach in which estrogen equivalents (EQs) in any mixture are equal to the sum of the concentration of the individual compounds (ECQ) times their potency (EPi) relative to an assigned standard such as diethylstilbestrol (DES) or E2 (51) . The total EQs in a mixture would be:
A similar approach is being used to determine the TCDD equivalents (TEQs) of various mixtures containing halogenated hydrocarbons (76) . Verdeal and Ryan (51) have previously used this approach with DES equivalents assuming that the oral potency of E2 is 15% that of DES. Winter (77) has estimated the dietary intake of pesticides based on FDA's total diet study, which includes estimates of food intakes and pesticide residue levels in these foods. The results presented in Table 2 summarize the estimated exposure of different groups to estrogenic pesticides. For example, 14 -to 16-year-old males were exposed to a total of 0.0416 pg/kg/day of the estrogenic pesticides, DDT, dieldrin, endosulfan, and p,p'-methoxychlor (note: the DDT value represents p,p'-DDE and related metabolites, which are primarily nonestrogenic). Thus, the overall dietary intake of these compounds by this age group was 2.5 pg/day.
The relative potencies of dietary and xenoestrogens are highly variable. The results of in vitro cell culture studies suggest that estrogenic potencies of bioflavonoids relative to E2 are 0.001 to 0.0001 (75, 78) whereas Soto and co-workers (44) have assigned an estrogen potency factor of 0.000001 for the estrogenic pesticides. These relative estrogen potency factors for bioflavonoids and pesticides may be lower when derived from in vivo studies since pharmacokinetic factors and metabolism may decrease bioavailability. Thus, a more accurate assessment of dietary/environmental EQs requires further data from dietary feeding studies that evaluate these compounds using the same experimental protocols.
The results in Table 3 summarize human exposure to dietary and environmental estrogens and the estimated daily dose in terms of EQs. The relative estrogenic intakes for various hormonal drug therapies were previously estimated by Verdeal and Ryan (51) ; the average estimated daily intake of all flavonoids in food products was 1020 and 1070 mg/day, Table 2 . Estimated dietary intake of estrogenic pesticides by different age groups based on food intakes and pesticide levels in these foodstuffs (7;) Estimated exposure (pg/kg/day) (71, 72) . The antiestrogen TEQs for the three classes of dietary AhR agonists are orders of magnitude higher than the estimated dietary intakes of estrogenic pesticide EQs. Thus, the major human intake of endocrine disrupters associated with the estrogen-induced response pathways are naturally occurring estrogens found in foods. Relatively high serum levels of estrogenic bioflavonoids have also been detected in a Japanese male population, whereas lower levels were observed in a Finnish group, and this is consistent with their dietary intakes of these estrogenic compounds (80) . p,p'-DDE is present in Volume 103, Number 4, April 1995ml human serum; however, the estrogenic o,p '-DDE and o,p '-DDT analogs and other weakly estrogenic organochlorine compounds are not routinely detected in serum samples. A recent study identified several hydroxylated PCB congeners in human serum. All of the hydroxylated compounds were also substituted with chlorine groups at both adjacent meta positions (81) . Based on results of previous structure-activity studies (43) for hydroxylated PCBs, these compounds would exhibit minimal estrogenic activity; however, further studies on the activity of hydroxylated PCBs are warranted.
Summary
The hypothesized linkage between dietary/environmental estrogens and the increased incidence of breast cancer is unproven; there is a lack of correlation between higher organochlorine levels in breast cancer patients compared to controls (Table 1 ) and the low levels of organochlorine EQs in the diet (Table 3 ). Higher levels of bioflavonoids are unlikely to contribute to increased breast cancer incidence because these compounds and the foods they are associated with tend to exhibit anticarcinogenic activity (82, 83 To-9-*e.9
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